Update: 21.09.2022
Last week: 36 week 2022 (05.09.2022 - 11.09.2022)
Last full month: Aug 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 144 276 | 18.3% | 3.7% | 0.1 | 29 021 966 | 19.2% | 3.7% | 0.1 | 15.0% |
| MoM | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| YTD | 7 140 572 | 2.5% | 5.7% | -0.3 | 1 411 638 628 | 20.6% | 5.4% | 0.1 | 7.4% |
| MAT | 13 442 832 | 25.7% | 6.2% | 0.9 | 2 531 371 330 | 46.2% | 5.8% | 1 | 8.0% |
| DEXALGIN | |||||||||
| WoW | 18 124 | 6.1% | 0.3% | 0 | 8 528 637 | 5.9% | 1.0% | 0 | 12.4% |
| MoM | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| YTD | 1 277 814 | 11.5% | 0.7% | 0.1 | 535 674 290 | 23.0% | 1.9% | 0.2 | 2.9% |
| MAT | 1 970 768 | 7.7% | 0.7% | 0 | 801 215 998 | 16.9% | 2.0% | 0.1 | 2.1% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 65 340 | 11.4% | 48.1% | 0.8 | 34 234 000 | 10.3% | 53.7% | 0.5 | 9.6% |
| MoM | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| YTD | 3 372 357 | -4.3% | 57.0% | -9.6 | 1 709 146 413 | 7.3% | 62.4% | -8 | 11.9% |
| MAT | 5 129 074 | 1.1% | 59.3% | -6.8 | 2 540 725 718 | 13.9% | 64.8% | -5.3 | 12.6% |
| ESPUMISAN BABY | |||||||||
| WoW | 25 208 | 6.3% | 33.3% | -0.5 | 16 454 784 | 6.7% | 47.0% | -0.3 | 8.0% |
| MoM | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| YTD | 1 044 160 | -9.8% | 38.2% | -3.7 | 647 827 588 | -3.6% | 51.6% | -5.2 | -1.0% |
| MAT | 1 549 900 | -10.8% | 38.8% | -2.7 | 947 370 060 | -3.1% | 52.5% | -3.1 | -4.5% |
| FASTUM | |||||||||
| WoW | 15 941 | 11.2% | 0.8% | 0 | 8 772 468 | 11.0% | 2.1% | 0 | 14.2% |
| MoM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| YTD | 781 390 | -19.1% | 1.2% | -0.3 | 400 623 123 | -9.7% | 2.6% | -0.6 | 1.3% |
| MAT | 1 200 357 | -17.3% | 1.2% | -0.3 | 597 374 837 | -8.7% | 2.7% | -0.5 | 0.9% |
| IODOMARIN | |||||||||
| WoW | 66 932 | 6.8% | 23.4% | 0.5 | 12 580 467 | 7.2% | 10.1% | 0 | 4.7% |
| MoM | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| YTD | 2 102 000 | 5.4% | 19.2% | 0 | 420 179 307 | 12.0% | 8.7% | 0 | 5.6% |
| MAT | 3 274 624 | 24.4% | 20.5% | 2.9 | 637 394 524 | 26.1% | 9.3% | 1.1 | 6.9% |
| LIOTON | |||||||||
| WoW | 19 315 | 3.4% | 1.9% | 0 | 20 790 781 | 3.9% | 4.1% | 0 | 5.3% |
| MoM | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| YTD | 987 945 | -20.9% | 2.4% | -0.4 | 1 007 668 463 | -0.7% | 4.8% | -0.8 | -6.6% |
| MAT | 1 430 705 | -17.4% | 2.5% | -0.3 | 1 395 943 298 | 1.4% | 5.0% | -0.6 | -6.5% |
| MEZYM | |||||||||
| WoW | 227 946 | 10.2% | 19.5% | -0.2 | 35 075 748 | 10.1% | 13.9% | -0.2 | 11.6% |
| MoM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| YTD | 13 748 433 | 5.4% | 28.1% | 0.7 | 2 103 914 284 | 14.8% | 20.1% | -0.4 | 2.9% |
| MAT | 21 460 637 | 12.3% | 29.5% | 1.8 | 3 179 843 157 | 19.1% | 21.3% | 0.4 | 5.3% |
| MIG 400 | |||||||||
| WoW | 154 966 | 9.2% | 2.9% | -0.1 | 18 441 953 | 9.5% | 2.2% | 0 | 12.4% |
| MoM | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| YTD | 6 117 953 | -8.6% | 3.4% | -0.4 | 718 679 524 | -4.7% | 2.6% | -0.5 | 2.9% |
| MAT | 9 318 063 | -0.6% | 3.5% | -0.1 | 1 081 309 830 | 3.3% | 2.7% | -0.2 | 2.1% |
| PROSTAMOL | |||||||||
| WoW | 23 675 | 23.2% | 15.4% | 0.8 | 32 762 317 | 22.4% | 16.3% | 1 | 16.6% |
| MoM | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| YTD | 1 161 669 | -20.3% | 19.8% | -5.3 | 1 630 317 846 | -10.5% | 21.2% | -6.3 | 1.0% |
| MAT | 1 844 449 | -13.0% | 21.1% | -3.5 | 2 508 400 377 | -4.6% | 22.4% | -4.5 | 1.6% |
| RESPERO MYRTOL | |||||||||
| WoW | 20 681 | 20.1% | 7.6% | -1.2 | 9 903 420 | 20.7% | 8.0% | -1.2 | 39.0% |
| MoM | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
| YTD | 849 768 | 173.6% | 9.0% | 5.5 | 396 424 939 | 166.6% | 8.8% | 4.8 | 7.7% |
| MAT | 1 285 961 | 130.1% | 8.4% | 4.4 | 592 593 313 | 119.8% | 8.2% | 3.6 | 10.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 140 572 | 2.5% | 5.7% | -0.3 | 1 411 638 628 | 20.6% | 5.4% | 0.1 | 7.4% |
| DEXALGIN | 1 277 814 | 11.5% | 0.7% | 0.1 | 535 674 290 | 23.0% | 1.9% | 0.2 | 2.9% |
| ESPUMISAN (ADULTS) | 3 372 357 | -4.3% | 57.0% | -9.6 | 1 709 146 413 | 7.3% | 62.4% | -8 | 11.9% |
| ESPUMISAN BABY | 1 044 160 | -9.8% | 38.2% | -3.7 | 647 827 588 | -3.6% | 51.6% | -5.2 | -1.0% |
| FASTUM | 781 390 | -19.1% | 1.2% | -0.3 | 400 623 123 | -9.7% | 2.6% | -0.6 | 1.3% |
| IODOMARIN | 2 102 000 | 5.4% | 19.2% | 0 | 420 179 307 | 12.0% | 8.7% | 0 | 5.6% |
| LIOTON | 987 945 | -20.9% | 2.4% | -0.4 | 1 007 668 463 | -0.7% | 4.8% | -0.8 | -6.6% |
| MEZYM | 13 748 433 | 5.4% | 28.1% | 0.7 | 2 103 914 284 | 14.8% | 20.1% | -0.4 | 2.9% |
| MIG 400 | 6 117 953 | -8.6% | 3.4% | -0.4 | 718 679 524 | -4.7% | 2.6% | -0.5 | 2.9% |
| PROSTAMOL | 1 161 669 | -20.3% | 19.8% | -5.3 | 1 630 317 846 | -10.5% | 21.2% | -6.3 | 1.0% |
| RESPERO MYRTOL | 849 768 | 173.6% | 9.0% | 5.5 | 396 424 939 | 166.6% | 8.8% | 4.8 | 7.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 13 442 832 | 25.7% | 6.2% | 0.9 | 2 531 371 330 | 46.2% | 5.8% | 1 | 8.0% |
| DEXALGIN | 1 970 768 | 7.7% | 0.7% | 0 | 801 215 998 | 16.9% | 2.0% | 0.1 | 2.1% |
| ESPUMISAN (ADULTS) | 5 129 074 | 1.1% | 59.3% | -6.8 | 2 540 725 718 | 13.9% | 64.8% | -5.3 | 12.6% |
| ESPUMISAN BABY | 1 549 900 | -10.8% | 38.8% | -2.7 | 947 370 060 | -3.1% | 52.5% | -3.1 | -4.5% |
| FASTUM | 1 200 357 | -17.3% | 1.2% | -0.3 | 597 374 837 | -8.7% | 2.7% | -0.5 | 0.9% |
| IODOMARIN | 3 274 624 | 24.4% | 20.5% | 2.9 | 637 394 524 | 26.1% | 9.3% | 1.1 | 6.9% |
| LIOTON | 1 430 705 | -17.4% | 2.5% | -0.3 | 1 395 943 298 | 1.4% | 5.0% | -0.6 | -6.5% |
| MEZYM | 21 460 637 | 12.3% | 29.5% | 1.8 | 3 179 843 157 | 19.1% | 21.3% | 0.4 | 5.3% |
| MIG 400 | 9 318 063 | -0.6% | 3.5% | -0.1 | 1 081 309 830 | 3.3% | 2.7% | -0.2 | 2.1% |
| PROSTAMOL | 1 844 449 | -13.0% | 21.1% | -3.5 | 2 508 400 377 | -4.6% | 22.4% | -4.5 | 1.6% |
| RESPERO MYRTOL | 1 285 961 | 130.1% | 8.4% | 4.4 | 592 593 313 | 119.8% | 8.2% | 3.6 | 10.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 144 276 | 18.3% | 3.7% | 0.1 | 29 021 966 | 19.2% | 3.7% | 0.1 | 15.0% |
| DEXALGIN | 18 124 | 6.1% | 0.3% | 0 | 8 528 637 | 5.9% | 1.0% | 0 | 12.4% |
| ESPUMISAN (ADULTS) | 65 340 | 11.4% | 48.1% | 0.8 | 34 234 000 | 10.3% | 53.7% | 0.5 | 9.6% |
| ESPUMISAN BABY | 25 208 | 6.3% | 33.3% | -0.5 | 16 454 784 | 6.7% | 47.0% | -0.3 | 8.0% |
| FASTUM | 15 941 | 11.2% | 0.8% | 0 | 8 772 468 | 11.0% | 2.1% | 0 | 14.2% |
| IODOMARIN | 66 932 | 6.8% | 23.4% | 0.5 | 12 580 467 | 7.2% | 10.1% | 0 | 4.7% |
| LIOTON | 19 315 | 3.4% | 1.9% | 0 | 20 790 781 | 3.9% | 4.1% | 0 | 5.3% |
| MEZYM | 227 946 | 10.2% | 19.5% | -0.2 | 35 075 748 | 10.1% | 13.9% | -0.2 | 11.6% |
| MIG 400 | 154 966 | 9.2% | 2.9% | -0.1 | 18 441 953 | 9.5% | 2.2% | 0 | 12.4% |
| PROSTAMOL | 23 675 | 23.2% | 15.4% | 0.8 | 32 762 317 | 22.4% | 16.3% | 1 | 16.6% |
| RESPERO MYRTOL | 20 681 | 20.1% | 7.6% | -1.2 | 9 903 420 | 20.7% | 8.0% | -1.2 | 39.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| DEXALGIN | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| ESPUMISAN (ADULTS) | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| ESPUMISAN BABY | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| FASTUM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| IODOMARIN | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| LIOTON | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| MEZYM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| MIG 400 | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| PROSTAMOL | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| RESPERO MYRTOL | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs